Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for AGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -57.30M
March 31, 2026 22.12M
December 31, 2025 -20.54M
September 30, 2025 -18.15M
June 30, 2025 -35.08M
March 31, 2025 -31.99M
December 31, 2024 16.42M
September 30, 2024 -7.703M
June 30, 2024 -18.72M
March 31, 2024 -47.78M
December 31, 2023 -61.17M
September 30, 2023 -13.02M
June 30, 2023 -21.20M
Date Value
March 31, 2023 -60.81M
December 31, 2022 -49.96M
September 30, 2022 2.647M
June 30, 2022 -60.26M
March 31, 2022 -23.23M
December 31, 2021 -48.90M
September 30, 2021 -19.14M
June 30, 2021 -39.29M
March 31, 2021 -40.83M
December 31, 2020 -13.34M
September 30, 2020 -4.367M
June 30, 2020 -9.371M
March 31, 2020 -26.13M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Astrana Health, Inc. 32.75M
Starling Oncology, Inc. 11.94M
Nakamoto, Inc. -3.253M
American Oncology Network, Inc. --
Tenet Healthcare Corp. 585.00M